Re: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

10BagR

Rank: Treasurer [?]

Points: 670 [?]

Votes: 20 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy

in response to

Re: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy

KOO-KOO2

posted on Oct 04, 2023 10:05AM

Here's a thought and I have no idea but...

Maybe RVX is going to go into this next phase 3 study with a lot of different primary end point possibilities hoping that at least one will statistically stick?

It's kind of like deploying a hope and a prayer strategy with a happy Hail Mary ending?